Browsing Tag
Stephen H. Willard
2 posts
Longeveron Inc. appoints Stephen H. Willard as CEO ahead of pivotal Phase 2b stem cell data
Find out why Longeveron Inc.’s CEO appointment comes at a critical clinical and financial moment and what it could mean for investors and regenerative medicine.
Cellphire Therapeutics raises $15m in Series A funding round
Cellphire Therapeutics, a Maryland-based biotech company focused on the long-term stabilization and storage of platelets, has raised $15…